Value stocks have outperformed their growth counterparts since the announcement of a Covid-19 vaccine last November. Investors have stopped chasing growth at any price and have gone back to looking for value in stock markets crowded with tech titans and expensive defensives. But can this value rally last, or will another Covid variant turn it on its head?
In this webinar, Josh Jones, Portfolio Manager of BP Global Premium Equities, will discuss the case for sustained value outperformance, plus the risk of growth reasserting itself. He will outline how the premium paid for growth stocks became so large, how reliant these styles are on the inflation and interest rate outlook, and how ESG impacts prospective returns to value in areas such as Energy and Materials.
The information contained in the website is solely intended for professional investors. Some funds shown on this website fall outside the scope of the Dutch Act on the Financial Supervision (Wet op het financieel toezicht) and therefore do not (need to) have a license from the Authority for the Financial Markets (AFM).
The funds shown on this website may not be available in your country. Please select your country website (top right corner) to view the products that are available in your country.
Neither information nor any opinion expressed on the website constitutes a solicitation, an offer or a recommendation to buy, sell or dispose of any investment, to engage in any other transaction or to provide any investment advice or service. An investment in a Robeco product should only be made after reading the related legal documents such as management regulations, prospectuses, annual and semi-annual reports, which can be all be obtained free of charge at this website and at the Robeco offices in each country where Robeco has a presence.